Literature DB >> 11907257

Identification of human herpesvirus 6 latency-associated transcripts.

Kazuhiro Kondo1, Kazuya Shimada, Junji Sashihara, Keiko Tanaka-Taya, Koichi Yamanishi.   

Abstract

Four kinds of latency-associated transcripts of human herpesvirus 6 were identified which were detected only in latently infected cells. Although they were oriented in the same direction as the immediate-early 1 and 2 (IE1/IE2) genes and shared their protein-coding region with IE1/IE2, their transcription start sites and exon(s) were latency associated.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11907257      PMCID： PMC136062          DOI： 10.1128/jvi.76.8.4145-4151.2002

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  31 in total

1.  Quantitative analysis of latent human cytomegalovirus.

Authors:  B Slobedman; E S Mocarski
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

2.  Detection of herpes simplex virus type 1 transcripts during latent infection in mice.

Authors:  J G Spivack; N W Fraser
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

3.  U94, the human herpesvirus 6 homolog of the parvovirus nonstructural gene, is highly conserved among isolates and is expressed at low mRNA levels as a spliced transcript.

Authors:  J C Rapp; L T Krug; N Inoue; T R Dambaugh; P E Pellett
Journal:  Virology       Date:  2000-03-15       Impact factor: 3.616

Review 4.  The family Herpesviridae: an update. The Herpesvirus Study Group of the International Committee on Taxonomy of Viruses.

Authors:  B Roizmann; R C Desrosiers; B Fleckenstein; C Lopez; A C Minson; M J Studdert
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

5.  Latent human herpesvirus 6 infection of human monocytes/macrophages.

Authors:  K Kondo; T Kondo; T Okuno; M Takahashi; K Yamanishi
Journal:  J Gen Virol       Date:  1991-06       Impact factor: 3.891

Review 6.  Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.

Authors:  M S Chee; A T Bankier; S Beck; R Bohni; C M Brown; R Cerny; T Horsnell; C A Hutchison; T Kouzarides; J A Martignetti
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

7.  Comparison of the complete DNA sequences of human herpesvirus 6 variants A and B.

Authors:  Y Isegawa; T Mukai; K Nakano; M Kagawa; J Chen; Y Mori; T Sunagawa; K Kawanishi; J Sashihara; A Hata; P Zou; H Kosuge; K Yamanishi
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

8.  A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency.

Authors:  D A Leib; C L Bogard; M Kosz-Vnenchak; K A Hicks; D M Coen; D M Knipe; P A Schaffer
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

9.  Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates.

Authors:  D V Ablashi; N Balachandran; S F Josephs; C L Hung; G R Krueger; B Kramarsky; S Z Salahuddin; R C Gallo
Journal:  Virology       Date:  1991-10       Impact factor: 3.616

10.  Human herpesvirus 6 (HHV-6) variant B accounts for the majority of symptomatic primary HHV-6 infections in a population of U.S. infants.

Authors:  S Dewhurst; K McIntyre; K Schnabel; C B Hall
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948
View more
  18 in total

1.  Recognition of a novel stage of betaherpesvirus latency in human herpesvirus 6.

Authors:  Kazuhiro Kondo; Junji Sashihara; Kazuya Shimada; Masaya Takemoto; Kiyoko Amo; Hiromi Miyagawa; Koichi Yamanishi
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

Review 2.  Roseolovirus molecular biology: recent advances.

Authors:  Laurie T Krug; Philip E Pellett
Journal:  Curr Opin Virol       Date:  2014-11-27       Impact factor: 7.090

Review 3.  Herpesvirus latency.

Authors:  Jeffrey I Cohen
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

Review 4.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

5.  Detection of a gene cluster that is dispensable for human herpesvirus 6 replication and latency.

Authors:  Kazuhiro Kondo; Hideo Nozaki; Kazuya Shimada; Koichi Yamanishi
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 6.  Laboratory and clinical aspects of human herpesvirus 6 infections.

Authors:  Henri Agut; Pascale Bonnafous; Agnès Gautheret-Dejean
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

7.  U94 of human herpesvirus 6 inhibits in vitro angiogenesis and lymphangiogenesis.

Authors:  Arnaldo Caruso; Elisabetta Caselli; Simona Fiorentini; Antonella Rotola; Alberto Prandini; Emirena Garrafa; Elisa Saba; Giulio Alessandri; Enzo Cassai; Dario Di Luca
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-16       Impact factor: 11.205

8.  Human herpesvirus 6 major immediate early promoter has strong activity in T cells and is useful for heterologous gene expression.

Authors:  Masaaki Matsuura; Masaya Takemoto; Koichi Yamanishi; Yasuko Mori
Journal:  Virol J       Date:  2011-01-11       Impact factor: 4.099

9.  Baculovirus-mediated promoter assay and transcriptional analysis of white spot syndrome virus orf427 gene.

Authors:  Liqun Lu; Hai Wang; Ivanus Manopo; Li Yu; Jimmy Kwang
Journal:  Virol J       Date:  2005-08-23       Impact factor: 4.099

10.  HHV-8-unrelated primary effusion-like lymphoma associated with clonal loss of inherited chromosomally-integrated human herpesvirus-6A from the telomere of chromosome 19q.

Authors:  Enjie Zhang; Victoria E Cotton; Alberto Hidalgo-Bravo; Yan Huang; Adam J Bell; Ruth F Jarrett; Gavin S Wilkie; Andrew J Davison; Ellie P Nacheva; Reiner Siebert; Aneela Majid; Inga Kelpanides; Sandrine Jayne; Martin J Dyer; Nicola J Royle
Journal:  Sci Rep       Date:  2016-03-07       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.